Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,495 | -52,531 | -24,068 | -101,660 | -68,705 |
| Depreciation Amortization | 9,274 | 4,024 | 2,032 | 7,975 | 5,843 |
| Accounts receivable | -2,161 | 2,290 | -2,271 | -8,141 | 111 |
| Other Working Capital | -5,060 | -1,851 | -4,359 | -4,841 | -2,529 |
| Other Operating Activity | 17,246 | 8,764 | 6,774 | 11,706 | -4,629 |
| Operating Cash Flow | $-63,196 | $-39,304 | $-21,892 | $-94,961 | $-69,909 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 17,604 | 12,604 |
| PPE Investments | -4,597 | -2,839 | -526 | -6,995 | -2,305 |
| Purchase Sale Intangibles | -1,000 | N/A | -1,250 | -2,400 | -2,400 |
| Other Investing Activity | -1,000 | 0 | -1,250 | 9,488 | 9,488 |
| Investing Cash Flow | $-5,597 | $-2,839 | $-1,776 | $20,097 | $19,787 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 15,000 | 15,000 |
| Debt Issued | 60,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -93,910 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 58,181 | 37,502 | 182 | 106,983 | 66,683 |
| Common Stock Repurchased | -70 | -70 | -70 | N/A | N/A |
| Dividend Paid | -4,557 | -2,788 | -1,207 | -2,559 | -1,773 |
| Other Financing Activity | 115,751 | 53,919 | 23,848 | 27,290 | 39,649 |
| Financing Cash Flow | $135,395 | $88,563 | $22,753 | $146,714 | $119,559 |
| Beginning Cash Position | 153,432 | 153,432 | 153,432 | 81,582 | 81,582 |
| End Cash Position | 220,034 | 199,852 | 152,517 | 153,432 | 151,019 |
| Net Cash Flow | $66,602 | $46,420 | $-915 | $71,850 | $69,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,196 | -39,304 | -21,892 | -94,961 | -69,909 |
| Capital Expenditure | -4,597 | -2,839 | -526 | -6,995 | -2,305 |
| Free Cash Flow | -67,793 | -42,143 | -22,418 | -101,956 | -72,214 |